Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solution ...

If you have diabetes, taking steps to manage it can help prevent related health issues, including MASH. Here’s what to know ...

Shares of Akero Therapeutics AKRO skyrocketed 105.7% in a week after the company announced initial positive top line 96-week data from a mid-stage study of its lead product candidate, efruxifermin ...

Akero Therapeutics, Inc. (NASDAQ:AKRO) released preliminary topline week 96 results from SYMMETRY Phase 2b study evaluating the efficacy and safety of its lead product candidate efruxifermin (EFX) in ...

in patients with biopsy-confirmed compensated cirrhosis (F4), Child-Pugh Class A, due to metabolic dysfunction-associated steatohepatitis (MASH). Among patients with baseline and week 96 biopsies ...

Traditionally, the liver biopsy has played a key role in the ... the presence of confounding patterns of injury (such as steatohepatitis coexisting with chronic viral hepatitis), and the presence ...

2011 Expert Reviews Ltd. Nonalcoholic steatohepatitis (NASH ... The presence of inflammation on liver biopsy is associated with the development of advanced fibrosis in NASH.

Fatty liver disease, or hepatic steatosis, occurs when excess fat accumulates in liver cells. Commonly associated with ...